— Know what they know.
Not Investment Advice

VNRX AMEX

VolitionRX Ltd
1W: -9.3% 1M: -37.6% 3M: -82.6% YTD: -13.9% 1Y: -62.2% 3Y: -67.6% 5Y: -92.8%
$0.23
+0.00 (+0.13%)
 
Weekly Expected Move ±9.8%
$0 $0 $0 $0 $0
AMEX · Healthcare · Medical - Devices · Tech Score Sell · Power 35 · $2.0M mcap · 7M float · 89.60% daily turnover · Short 42% of daily vol

Supply Chain Overview

5 relationships
5
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2022-03-29
Earliest Filing
2026-01-08
Latest Filing
partner: 4 investor: 1

Counterparties (Filed by VNRX)

5 relationships

Companies named in VNRX's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
Lind Global Asset Management XII LLC — investor Investor providing $2M funding in exchange for a Senior Secured Convertible Promissory Note and Common Stock Purchase Wa 2026-01-08 View
VStock Transfer, LLC — partner Warrant Agent for the offering 2025-10-14 View
JonesTrading Institutional Services LLC — partner Sales agent for the Capital On DemandTM Sales Agreement 2025-04-22 View
Jefferies LLC JEF partner Counterparty to the terminated Prior ATM Agreement 2025-04-22 View
Heska Corporation — partner VolitionRx entered into a License and Supply Agreement granting Heska exclusive rights to sell the Nu.Q Vet Cancer Scree 2022-03-29 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-09-25 Unregistered Equity Sales View
2026-09-15 Unregistered Equity Sales View
2026-09-14 Other Events; Exhibits View
2026-09-02 Unregistered Equity Sales View
2026-09-02 Material Agreement; Exhibits Agreement View
2026-08-24 Unregistered Equity Sales View
2026-08-13 Earnings Release; Exhibits View
2026-08-07 Unregistered Equity Sales View
2026-07-21 Bylaws Amendment; Shareholder Vote; Exhibits View
2026-06-18 Unregistered Equity Sales View
2026-06-10 Material Agreement; Other Events; Exhibits Agreement View
2026-05-22 Material Agreement Agreement View
2026-05-15 Officer/Director Change View
2026-05-14 Earnings Release; Exhibits View
2026-04-28 Bylaws Amendment; Exhibits View
2026-04-23 Delisting Notice; Other Events; Exhibits View
2026-04-17 Other Events View
2026-04-01 Shareholder Vote View
2026-03-31 Earnings Release; Exhibits View
2026-02-20 Unregistered Sales of Equity Securities; Financial Statements and Exhibits View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms